Atorvastatin Treatment Prevents Alterations in Coronary Smooth Muscle Nuclear Ca2+ Signaling in Diabetic Dyslipidemia

Brian R. Wamhoff,Joseph L. Dixon,Michael Sturek

Atorvastatin Treatment Prevents Alterations in Coronary Smooth Muscle Nuclear Ca2+ Signaling in Diabetic Dyslipidemia

2002

Brian R. Wamhoff
Joseph L. Dixon
Michael Sturek

Atorvastatin, an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, alters bulk myoplasmic Ca2+ regulation and inhibits phenotypic modulation and proliferation of vascular smooth

Keywords:

Anatomy
Vascular disease
Vascular smooth muscle
Signal transduction
Dyslipidemia
Cholesterol
Endothelin receptor
Atorvastatin
Internal medicine
Biology
Coenzyme A
Endocrinology
Reductase
Hydroxymethylglutaryl-CoA reductase
Circulatory system

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations